Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cutis laxa is a rare connective tissue disorder primarily caused by mutations in genes responsible for the production and maintenance of elastic fibers, such as ELN, FBLN5, and ATP6V0A2. While many cases are inherited through genetic pathways, cutis laxa can also manifest as an acquired condition due to systemic inflammation or autoimmune processes, though the exact underlying mechanism remains an active area of clinical research. What causes Cutis Laxa at a genetic level? The structural integrity of our skin, blood vessels, and lungs depends on elastic fibers.
Cutis laxa is a rare connective tissue disorder primarily caused by mutations in genes responsible for the production and maintenance of elastic fibers, such as ELN, FBLN5, and ATP6V0A2. While many cases are inherited through genetic pathways, cutis laxa can also manifest as an acquired condition due to systemic inflammation or autoimmune processes, though the exact underlying mechanism remains an active area of clinical research.
The structural integrity of our skin, blood vessels, and lungs depends on elastic fibers. In genetic forms of cutis laxa, mutations disrupt the assembly or stability of these fibers. Think of elastic fibers like a rubber band; in this condition, the "rubber" is either not manufactured correctly or is broken down too quickly by the body’s enzymes. Inheritance patterns vary significantly:
Unlike hereditary forms, acquired cutis laxa usually appears later in life. It is not caused by a single gene mutation but is often triggered by an abnormal immune response. Researchers suspect that in these cases, the body’s own immune system accidentally attacks the elastic fibers, leading to the skin laxity characteristic of cutis laxa. This has been observed following severe drug reactions, infections, or underlying autoimmune conditions.
While we have identified several key genes involved in cutis laxa, the condition is highly heterogeneous, meaning different patients may have vastly different clinical presentations. Scientists are currently using advanced genetic sequencing to uncover "modifier genes" that might explain why two people with the same mutation experience different levels of disease severity. Understanding these pathways is crucial for developing future targeted therapies.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.